Study of Danicopan in Participants With Hepatic Impairment

NCT03555539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Danicopan

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]